Thymosin α-1.

Quick Overview.

Thymosin Alpha-1 (TA1) is a highly conserved, 28-amino acid peptide originally isolated from the thymus gland. The thymus is the "training camp" for your immune system, where T-cells learn to differentiate between foreign invaders and your own healthy tissue. As we age, the thymus naturally shrinks (involution), leading to a weaker immune response.[1]

TA1 acts as a master immune system modulator. It does not simply "boost" the immune system; rather, it balances it. If your immune system is underactive (e.g., fighting a chronic viral infection), TA1 stimulates the production and maturation of T-cells to fight the pathogen. If your immune system is overactive (e.g., in certain autoimmune conditions), TA1 helps regulate the response to prevent tissue damage.[2]

• Primary Use Case: Chronic viral infections (EBV, Hepatitis, Long COVID), mold toxicity, Lyme disease, and general immune system restoration.
• Mechanism: Stimulates the maturation of T-cells (specifically CD4+ and CD8+ cells) and enhances the production of key cytokines like interferon-gamma and interleukin-2.[3]
• Who it is for: Individuals suffering from chronic, stubborn infections, or those with compromised immune systems due to aging or severe stress.
• Who it is NOT for: Organ transplant recipients (due to the risk of immune-mediated rejection).

The Protocol & Usage Guide.

confidence_tier: well-established

TA1 is typically administered via subcutaneous injection. Because it is modulating the immune system rather than directly killing pathogens, it requires consistent dosing over several weeks to see full effects.

Standard Dosing

Cycle Length

• Standard Cycle: 4 to 12 weeks, depending on the severity of the infection or immune suppression.
• Discontinuation: Can be stopped abruptly without a taper.

Reconstitution Math

• Vial Size: 10 mg (10,000 mcg)
• Bacteriostatic Water Added: 2 mL
• Concentration: 5,000 mcg per mL
• To draw 1.5 mg (1,500 mcg): Pull to the 30-unit mark (0.3 mL) on a U-100 insulin syringe.

Nutritional Support & Recommended Supplements.

confidence_tier: well-established

Safety, Interactions & Side Effect Management.

confidence_tier: well-established

TA1 is exceptionally safe and well-tolerated, as it is a naturally occurring peptide.

Side Effect Profile

Contraindications

• Absolute: Organ transplant recipients (TA1 stimulates the immune system, which could lead to organ rejection).
• Relative: Individuals with severe, uncontrolled autoimmune diseases (e.g., Lupus, Rheumatoid Arthritis) should consult a physician, as immune stimulation can be unpredictable.

Drug Interactions

• Immunosuppressants: TA1 will directly counteract drugs designed to suppress the immune system (e.g., post-transplant medications).
• Vaccines: TA1 is clinically used as a vaccine adjuvant to increase the body's antibody response to vaccines.[4]

Common Stacks & Combinations.

confidence_tier: community

Body Composition & Training Guide.

confidence_tier: community

TA1 is not a performance-enhancing drug for muscle growth or fat loss.

• Overtraining: Its primary use in athletics is preventing the severe immune suppression that occurs during extreme overtraining or marathon/Ironman prep. It keeps athletes from getting sick right before a competition.
• Tracking Progress: Track subjective feelings of fatigue, frequency of illness, and specific symptoms of chronic viral infections.

Storage, Handling & Accessibility.

confidence_tier: well-established

• Unreconstituted (Lyophilized Powder): Store in the freezer (-20°C) for up to 24 months.
• Reconstituted (Liquid): Must be stored in the refrigerator (2-8°C). Good for 30 days.
• WADA Status: Not explicitly banned, as it is not an anabolic agent or hormone secretagogue.

Bloodwork Monitoring Guide.

confidence_tier: emerging

If using TA1 to treat a specific chronic infection, monitor:

• Complete Blood Count (CBC) with Differential: To monitor white blood cell and lymphocyte counts.
• Viral Titers: (e.g., EBV antibodies, Hepatitis viral load) to track the clearance of the infection.
• CD4/CD8 T-Cell Ratio: To monitor immune system balance.

Comparison to Similar Compounds.

confidence_tier: well-established

Deep Dive (For Advanced Researchers).

confidence_tier: well-established

Mechanism of Action

Thymosin Alpha-1 (Thymalfasin) is a highly conserved, 28-amino acid acidic peptide originally isolated from calf thymus tissue.

• T-Cell Maturation: TA1 acts primarily on the thymus gland to stimulate the maturation of naive T-cells into active CD4+ (helper) and CD8+ (cytotoxic) T-cells.[2]
• Cytokine Production: It upregulates the production of key Th1 cytokines, including interferon-gamma (IFN-γ) and interleukin-2 (IL-2), which are essential for mounting a robust antiviral and anti-tumor response.[3]
• Toll-Like Receptors (TLRs): TA1 has been shown to interact with Toll-like receptors (specifically TLR9) on dendritic cells, bridging the innate and adaptive immune systems.[5]

Clinical Trial Summary

• Hepatitis B and C: TA1 (under the brand name Zadaxin) has been extensively studied and approved in over 30 countries for the treatment of chronic Hepatitis B and C, often used in combination with interferon therapy to improve viral clearance rates.[6]
• Sepsis: Meta-analyses of randomized controlled trials have shown that TA1 administration significantly reduces 28-day mortality in patients with severe sepsis by reversing sepsis-induced immunosuppression.[7]
• COVID-19: During the pandemic, TA1 was utilized in several clinical trials to treat severe COVID-19. Studies demonstrated that TA1 reduced mortality by restoring lymphocytopenia (low white blood cell count) and reversing exhausted T-cells in severe cases.[8]

Frequently Asked Questions (FAQ).

confidence_tier: community

Q: Will TA1 cure my autoimmune disease? A: TA1 is an immune modulator, not an immunosuppressant. While some users report improvements in autoimmune symptoms due to its balancing effect, it can theoretically exacerbate certain conditions by stimulating the immune system. Consult a physician before use.

Q: Why did the FDA ban compounding pharmacies from making it? A: In late 2023, the FDA reclassified TA1 as a biologic and banned compounding pharmacies from producing it, citing a lack of safety data—despite it being an approved drug (Zadaxin) in 35 other countries. This forced users to rely entirely on the research chemical market.

Q: Can I take it if I feel a cold coming on? A: Yes. Many users keep a vial of TA1 on hand and inject 1.5 mg at the first sign of a viral infection (cold or flu) to rapidly mount an immune response and shorten the duration of the illness.

International Regulatory Status.

confidence_tier: well-established

Decision Tree.

confidence_tier: community

[Goal: Immune System Support?]
  |
  +-- Are you an organ transplant recipient?
        |
        +-- (Yes) -> STOP: TA1 is strictly contraindicated.
        |
        +-- (No) -> Are you fighting a chronic viral infection (EBV, Hep, Long COVID)?
              |
              +-- (Yes) -> Use TA1 (1.5mg daily) until symptoms resolve.
              |
              +-- (No, just general immune support/anti-aging) -> Use TA1 (1.0-1.5mg 2-3x weekly).

Schema.org Data.

{
  "@context": "https://schema.org",
  "@type": "MedicalEntity",
  "name": "Thymosin Alpha-1",
  "alternateName": ["TA1", "Thymalfasin", "Zadaxin"],
  "description": "A 28-amino acid peptide that acts as a master immune system modulator, stimulating T-cell maturation and cytokine production to fight chronic viral infections and restore immune homeostasis.",
  "legalStatus": {
    "@type": "DrugLegalStatus",
    "description": "Approved as a prescription drug in 35+ countries (Zadaxin); unapproved by the US FDA and banned from compounding pharmacies. Not prohibited by WADA."
  }
}

What we cited.